Biomanufacturing Specialists
Alpha Biologics is an independent, privately owned company with R&D and production facilities in the UK and Malaysia, respectively. The two main operating bases are:
- R&D and bioprocess development laboratories located on the Babraham Research Campus, Cambridge, at the heart of the UK's biotechnology industry
- A 5,000 sq metre advanced cGMP biomanufacturing facility for mammalian cell culture on Penang Science Park, Malaysia.
Our ethos is to combine the scientific, technological and economic advantages of East and West. By doing this we provide flexible, cost-effective cGMP services that minimise cost and accelerate product development towards final market use. On all Alpha Biologics sites, teams of specialists with global cGMP manufacturing experience ensure that the highest standards of production and regulatory compliance are met.
Alpha Biologics provide contract biomanufacturing services, providing clients with supplies of mammalian cell proteins, such as monoclonal antibodies or recombinant proteins, or other cell-derived products. These are supplied for pre-clinical, clinical trial or final market use. Our team includes:
Michelle Peake, Chief Operating Officer
15 years of experience in the cGMP manufacture of biologic or biopharmaceutical materials with companies such as Xenova, Cantab (UK) and Agen (Australia)
Mark Doran, Director of Process Development & Manufacturing
15 years experience in global pharmaceutical companies such as Abbott Laboratories on process development and the cGMP manufacture of biologic materials, including monoclonal antibodies and purified proteins for diagnostic use, assay kit diluents or enzyme-linked conjugation
Rod Smith, Director of Technology Transfer
Over 20 years experience in the biotechnology industry, with particular expertise in process development and cGMP manufacturing in mammalian and bacterial systems. Rod has been involved in the development and production of antibody and other products for a range of respected organisations including the UK Health Protection Agency (CAMR), the European Collection of Animal Cell Collections (Porton Down), Cantab Pharmaceuticals, Xenova, and UCB.
Kishin Kumar, Finance Controller
A Chartered Accountant with 20 years of experience in Accounting, Financial Management and Cash Management with major companies such as Serco, Bull, British Airports Authority and South African Airways.
Michael Joachim - Process Development and Method Optimisation
Nine years of experience in organisations such as MedImmune and Xenova working on a wide range of cells and organism types including CHO, E. coli, Mycobacterium, S. aureus, Green Monkey kidney cells and Herpes Simplex virus.
Emma Ward - Downstream Processing and Analytical Method Development
18 years of relevant biotechnology and bioprocess experience with organisations such as Xenova and Prometic.
Lim Jian Han, GMP Facility Manager
Six years of hands-on pharmaceuticals engineering experience in the cGMP manufacturing of pharmaceuticals and medical devices with B.Braun Medical Industries.
Ashfaq Ahmed - cGMP Area Manager
10 years of biopharmaceutical manufacturing experience, producing materials for Phase I-III clinical trials and commercial use, with particular emphasis on cGMP operations, technology transfer and the cGMP validation of processes and equipment.
Ravi More, Process Development Manager
12 years of experience in bioprocess development & optimization, including process scale-up & scale-down, technology transfer, process characterization & validation, analytical method development & optimisation, protein analysis & characterization.
Lee Mei Ping, QA Manager
10 years of experience in creating and maintaining quality systems. An experienced manager of quality control, quality assurance, validation and regulatory affairs within GMP pharmaceutical manufacturing and GLP pre-clinical toxicology research institutions.
